Product Information
NAPROXEN SODIUM 220 MG TABLET is a generic product labeled by Camber Consumer Care, priced at $0.0673 per EA under NDC 69230032910. Its NADAC has been published 102 times since Oct 23, 2024.
FDA first approved this application on Oct 28, 2022.
Strength
220 mg/1
Manufacturer
Camber Consumer CareNDC
69230032910
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA211065FDA Approved
10/28/2022
On Market Since
10/28/2022
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN SODIUM 220 MG TABLET has been published 102 times since Oct 23, 2024, and over the history we have for it it has risen 5.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0673 per EA |
|---|---|
| All-time high | $0.0683 (Aug 12, 2026) |
| All-time low | $0.0625 (Jun 18, 2025) |
| 52-week high | $0.0683 |
| 52-week low | $0.0635 |
| Median price | $0.0650 |
| Average price | $0.0652 |
| Largest weekly change | +3.0% (Jul 22, 2026) |
| Weeks tracked | 102 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Consumer Care manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPROXEN SODIUM 220 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN SODIUM 220 MG TABLET, manufactured by Camber Consumer Care, is $0.0673 per EA (NDC 69230032910), effective Sep 30, 2026.
How has the price of NAPROXEN SODIUM 220 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN SODIUM 220 MG TABLET has risen 5.2%. It has been tracked across 102 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for NAPROXEN SODIUM 220 MG TABLET?
Since Oct 23, 2024, the NADAC for NAPROXEN SODIUM 220 MG TABLET has ranged from a low of $0.0625 (Jun 18, 2025) to a high of $0.0683 (Aug 12, 2026), with a median of $0.0650 per EA.
Are there cheaper alternatives to NAPROXEN SODIUM 220 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as NAPROXEN SODIUM 220 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NAPROXEN SODIUM 220 MG TABLET?
NAPROXEN SODIUM 220 MG TABLET (NDC 69230032910) is labeled by Camber Consumer Care, and CMS classifies it as a generic product.